Enhanced recovery after surgery in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: national survey of peri-operative practice by Indian society of peritoneal surface malignancies.

IF 1.4 Q4 ONCOLOGY Pleura and Peritoneum Pub Date : 2023-05-22 eCollection Date: 2023-06-01 DOI:10.1515/pp-2022-0198
Sampige Prasanna Somashekhar, Suryanarayana Deo, Subramanyeshwar Rao Thammineedi, Harit Chaturvedi, Ganesh Mandakukutur Subramanya, Rama Joshi, Jagdish Kothari, Ayyappan Srinivasan, Kumar C Rohit, Mukurdipi Ray, Bharat Prajapati, Hemanth Guddahatty Nanjappa, Rajagopalan Ramalingam, Aaron Fernandes, Kyatsandra Rajagopal Ashwin
{"title":"Enhanced recovery after surgery in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: national survey of peri-operative practice by Indian society of peritoneal surface malignancies.","authors":"Sampige Prasanna Somashekhar, Suryanarayana Deo, Subramanyeshwar Rao Thammineedi, Harit Chaturvedi, Ganesh Mandakukutur Subramanya, Rama Joshi, Jagdish Kothari, Ayyappan Srinivasan, Kumar C Rohit, Mukurdipi Ray, Bharat Prajapati, Hemanth Guddahatty Nanjappa, Rajagopalan Ramalingam, Aaron Fernandes, Kyatsandra Rajagopal Ashwin","doi":"10.1515/pp-2022-0198","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The Enhanced recovery after surgery (ERAS) program is designed to achieve faster recovery by maintaining pre-operative organ function and reducing stress response following surgery. A two part ERAS guidelines specific for Cytoreductive surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) was recently published with intent of extending the benefit to patients with peritoneal surface malignancies. This survey was performed to examine clinicians' knowledge, practice and obstacles about ERAS implementation in patients undergoing CRS and HIPEC.</p><p><strong>Methods: </strong>Requests to participate in survey of ERAS practices were sent to 238 members of Indian Society of Peritoneal Surface malignancies (ISPSM) via email. They were requested to answer a 37-item questionnaire on elements of preoperative (n=7), intraoperative (n=10) and postoperative (n=11) practices. It also queried demographic information and individual attitudes to ERAS.</p><p><strong>Results: </strong>Data from 164 respondents were analysed. 27.4 % were aware of the formal ERAS protocol for CRS and HIPEC. 88.4 % of respondents reported implementing ERAS practices for CRS and HIPEC either, completely (20.7 %) or partially (67.7 %). The adherence to the protocol among the respondents were as follows: pre operative (55.5-97.6 %), intra operative (32.6-84.8 %) and post operative (25.6-89 %). While most respondents considered implementation of ERAS for CRS and HIPEC in the present format, 34.1 % felt certain aspects of perioperative practice have potential for improvement. The main barriers to implementation were difficulty in adhering to all elements (65.2 %), insufficient evidence to apply in clinical practice (32.4 %), safety concerns (50.6 %) and administrative issues (47.6 %).</p><p><strong>Conclusions: </strong>Majority agreed the implementation of ERAS guidelines is beneficial but are followed by HIPEC centres partially. Efforts are required to overcome barriers like improving certain aspects of perioperative practice to increase the adherence, confirming the benefit and safety of protocol with level I evidence and solving administrative issues by setting up dedicated multi-disciplinary ERAS teams.</p>","PeriodicalId":20231,"journal":{"name":"Pleura and Peritoneum","volume":"8 2","pages":"91-99"},"PeriodicalIF":1.4000,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249752/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pleura and Peritoneum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/pp-2022-0198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The Enhanced recovery after surgery (ERAS) program is designed to achieve faster recovery by maintaining pre-operative organ function and reducing stress response following surgery. A two part ERAS guidelines specific for Cytoreductive surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) was recently published with intent of extending the benefit to patients with peritoneal surface malignancies. This survey was performed to examine clinicians' knowledge, practice and obstacles about ERAS implementation in patients undergoing CRS and HIPEC.

Methods: Requests to participate in survey of ERAS practices were sent to 238 members of Indian Society of Peritoneal Surface malignancies (ISPSM) via email. They were requested to answer a 37-item questionnaire on elements of preoperative (n=7), intraoperative (n=10) and postoperative (n=11) practices. It also queried demographic information and individual attitudes to ERAS.

Results: Data from 164 respondents were analysed. 27.4 % were aware of the formal ERAS protocol for CRS and HIPEC. 88.4 % of respondents reported implementing ERAS practices for CRS and HIPEC either, completely (20.7 %) or partially (67.7 %). The adherence to the protocol among the respondents were as follows: pre operative (55.5-97.6 %), intra operative (32.6-84.8 %) and post operative (25.6-89 %). While most respondents considered implementation of ERAS for CRS and HIPEC in the present format, 34.1 % felt certain aspects of perioperative practice have potential for improvement. The main barriers to implementation were difficulty in adhering to all elements (65.2 %), insufficient evidence to apply in clinical practice (32.4 %), safety concerns (50.6 %) and administrative issues (47.6 %).

Conclusions: Majority agreed the implementation of ERAS guidelines is beneficial but are followed by HIPEC centres partially. Efforts are required to overcome barriers like improving certain aspects of perioperative practice to increase the adherence, confirming the benefit and safety of protocol with level I evidence and solving administrative issues by setting up dedicated multi-disciplinary ERAS teams.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
腹膜表面恶性肿瘤:印度腹膜表面恶性肿瘤学会对全国围手术期实践的调查:细胞剥脱手术和腹腔内热化疗术后恢复的提高。
目标:加强术后恢复(ERAS)计划旨在通过保持术前器官功能和减少术后应激反应来加快恢复速度。最近,针对细胞再生手术(CRS)和腹腔内热化疗(HIPEC)发布了两部分ERAS指南,旨在将腹膜表面恶性肿瘤患者也纳入受益范围。本调查旨在了解临床医生对接受 CRS 和 HIPEC 治疗的患者实施 ERAS 的知识、实践和障碍:通过电子邮件向印度腹膜表面恶性肿瘤学会(ISPSM)的 238 名会员发出了参与 ERAS 实践调查的请求。他们被要求回答一份包含 37 个项目的问卷,内容涉及术前(7 个)、术中(10 个)和术后(11 个)的实践。问卷还询问了人口统计学信息和个人对 ERAS 的态度:对 164 名受访者的数据进行了分析。27.4%的受访者知道针对 CRS 和 HIPEC 的正式 ERAS 协议。88.4%的受访者表示完全(20.7%)或部分(67.7%)实施了 CRS 和 HIPEC 的 ERAS 操作。受访者遵守协议的情况如下:术前(55.5%-97.6%)、术中(32.6%-84.8%)和术后(25.6%-89%)。虽然大多数受访者认为 CRS 和 HIPEC 的 ERAS 目前的实施形式尚可,但 34.1% 的受访者认为围手术期实践的某些方面还有改进的余地。实施的主要障碍是难以遵守所有要素(65.2%)、在临床实践中应用的证据不足(32.4%)、安全问题(50.6%)和行政问题(47.6%):结论:大多数人认为实施 ERAS 指南是有益的,但 HIPEC 中心只是部分遵守。需要努力克服障碍,如改进围手术期实践的某些方面以提高遵守率,用一级证据确认方案的益处和安全性,以及通过成立专门的多学科 ERAS 小组来解决行政问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.50
自引率
11.10%
发文量
23
审稿时长
9 weeks
期刊最新文献
Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial). Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery. Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis. In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens. Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1